Helen F. Graham Cancer Center

ChristianaCare researchers identified a developmental genetic pattern that showed how colorectal cancer develops. The findings revealed that certain types of genes drive cancer growth and resistance, and how the precise timing of how they develop is linked to colon cancer formation.The research team’s work also showed the genes can predict survival in colorectal cancer patients, indicating it can be a marker of disease behavior and a target for future therapies.This week, Delaware Public Media’s Joe Irizarry sat down with Bruce Boman, M.D., senior author of the study and senior researcher at ChristianaCare’s Helen F. Graham Cancer Center & Research Institute to discuss this colorectal cancer research.

ChristianaCare is starting to offer primary care treatment to patients at its cancer center.A recent survey of cancer patients at the Helen F. Graham…

A symposium at ChristianaCare this week focused on the latest gene editing breakthroughs and the challenges of getting these new technologies to…

ChristianaCare is using a new cancer treatment on its patients.The U.S. Food and Drug Administration (FDA) first approved CAR-T Cell therapy in 2017 for…

Christiana Care Health System is getting a financial boost for its cancer research. Christiana Care’s Helen F. Graham Cancer Center & Research Institute…

Doctors at Christiana Care Health System’s Helen F. Graham Cancer Center are saying 2019 and 2020 will be breakout years for the gene editing technique…

Christiana Care Health System researchers have discovered a new way to use CRISPR gene-editing techniques to potentially reduce the need for chemotherapy…

Lung cancer is the leading cause of cancer deaths in Delaware and nationwide, which is why doctors at Christiana Care Health System are working towards…